Translational Research
Volume 155, Issue 5 , Pages 238-246, May 2010

Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease—KOZANI STUDY

  • Nikolaos P.E. Kadoglou

      Affiliations

    • Department of Cardiology, “Mamatsio” General Hospital, Kozani, Greece
    • Center of Experimental Surgery, Biomedical Research Foundation, Academy of Athens, Greece
    • Corresponding Author InformationReprint requests: Nikolaos P. E. Kadoglou, Department of Cardiology, “Mamatsio” General Hospital, 124 Vosporou str, GR-54454 Thessaloniki, Greece;
  • ,
  • Stilianos Lampropoulos

      Affiliations

    • Department of Cardiology, “Mamatsio” General Hospital, Kozani, Greece
  • ,
  • Alkistis Kapelouzou

      Affiliations

    • Center of Experimental Surgery, Biomedical Research Foundation, Academy of Athens, Greece
  • ,
  • Argirios Gkontopoulos

      Affiliations

    • Department of Cardiology, “Mamatsio” General Hospital, Kozani, Greece
  • ,
  • Efstratios K. Theofilogiannakos

      Affiliations

    • Department of Cardiology, “Mamatsio” General Hospital, Kozani, Greece
  • ,
  • Grigorios Fotiadis

      Affiliations

    • First Department of Internal Medicine, “Hippokratio” General Hospital, Thessaloniki, Greece
  • ,
  • George Kottas

      Affiliations

    • Department of Cardiology, “Mamatsio” General Hospital, Kozani, Greece

Received 28 November 2009; received in revised form 22 January 2010; accepted 23 January 2010. published online 22 February 2010.

Apelin and ghrelin have emerged as novel adipokines, but their role in coronary artery disease (CAD) remains obscure. In the present study, we analyzed their serum levels in patients with acute coronary syndromes (ACS) or established asymptomatic CAD. A total of 355 participants were enrolled. Among them were 80 patients with unstable angina (UA) and 115 patients with acute myocardial infarction (AMI) hospitalized in the coronary care unit. We also included 88 asymptomatic patients with established CAD (asymptomatic CAD) and 72 age-and sex-matched healthy controls (HCs). All groups with CAD underwent coronary angiography, and the Gensini score was determined. Clinical parameters, glycemic and lipid profile, high-sensitivity CRP (hsCRP), insulin resistance (HOMA-IR), as well as apelin and ghrelin were assayed. Patients with ACS (UA or AMI) were sampled at hospital admission. All 3 groups with CAD (UA, AMI, or asymptomatic CAD) showed significantly higher levels of hsCRP, HOMA-IR, and white blood cells than controls (P < 0.01). Conversely, apelin and ghrelin concentrations were considerably (P < 0.05) lower in CAD patients with respect to the control group. Most importantly, UA (6.72 ± 3.51 ng/mL) and AMI (6.02 ± 4.07 ng/mL) groups had even lower apelin levels on admission compared with the asymptomatic CAD group (13.53 ± 5.2 ng/mL) (P < 0.05). Logistic regression analysis showed an independent association of low apelin and ghrelin levels with CAD presence. Besides this result, apelin showed an inverse relationship with ACS incidence and a Gensini score independent of other cardiovascular risk factors (P < 0.05). In conclusion, CAD seemed to correlate with low serum apelin and ghrelin levels. Moreover, apelin concentrations inversely were associated with the severity and the acute phase of CAD, which suggests its involvement in the progression and destabilization of coronary atherosclerotic plaques.

Abbreviations: ACS, acute coronary syndrome, ADA, American Diabetes Association, AMI, acute myocardial infarction, BMI, body-mass index, CAD, coronary artery disease, ECG, electrocardiogram, FPG, fasting plasma glucose, GHS-R, growth hormone secretagogue receptor, HbA1c, glycosylated hemoglobin, HC, healthy controls, HOMA-IR, insulin resistance, hsCRP, high-sensitivity CRP, LAD, left anterior descending, LCX, left circumflex, LDL-C, low-density lipoprotein cholesterol, UA, unstable angina, WBC, white blood cell

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Alexander S. Onassis Public Benefit Foundation.

PII: S1931-5244(10)00029-0

doi:10.1016/j.trsl.2010.01.004

Translational Research
Volume 155, Issue 5 , Pages 238-246, May 2010